Sector revisions Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 06:41:30 10/07/2025 pm IST			5-day change	1st Jan Change
443.45 ^DKK	+0.09%		+1.74%	-28.63%

09/07	Major deals involving U.S. drugmakers and biotechs over the past decade	RE
09/07	European shares close at four-week high on banks boost; US trade talks in focus	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
	NOVO NORDISK A/S							22
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							23
	ABBVIE INC.							27
	ROCHE HOLDING AG							20
	NOVARTIS AG							19
	ASTRAZENECA PLC							20
	MERCK & CO., INC.							24
	AMGEN INC.							28
	PFIZER, INC.							23
	GILEAD SCIENCES, INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							28
	SANOFI							23
	BRISTOL-MYERS SQUIBB COMPANY							21
	GSK PLC							19
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	JIANGSU HENGRUI MEDICINE CO., LTD.							18
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	HALEON PLC							17
	Average							22
	Weighted average by Cap.							23